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Linkage disequilibrium between a
marker on the low-density lipoprotein
receptor and high cholesterol levels
P. A. BRINK, L. T. STEYN, A. J. BESTER, KRISELA STEYN
Summary
We describe the presence of a linkage disequilibrium
between high cholesterol levels in Afrikaner indivi-
duals and the common allele of the Pvu 11 restriction
fragment polymorphism on the low-density lipoprotein
(LDL) receptor gene. The frequencies of the common
and the rare allele in a sample of the Afrikaner
population were 0,654 and 0,346 (65 individuals) and
0,794 and 0,206 in the hypercholesterolaemic popu-
lation (34 patients) (P < 0,05). This finding supports
other evidence for a founder origin of the nigh
frequency ()f familial hypercholesterolaemia among
Afrikaners.
S Air Med J , 986: 70: 80-82-
Familial hypercholesterolaemia (FH) is an autosomally domi-
nantly inherited form of hypercholesterolaemia with a hetero-
zygote frequency of I in 100 (conservatively calculated) among
Transvaal Afrikaners,I,2 five times that reported from other
Western countries. 3 A founder effect in the Afrikaner popula-
tion has been suggested. I ,2,. FH is characterized by high serum
cholesterol and high low-density lipoprotein (LDL) cholesterol
levels, tendon xanthomas, xanthelasma and an increased risk
of myocardial infarction after the age of 35 years. 3 The homo-
zygote frequency in South Africa is reported to be I in
30000.2 Survival for homozygously affected individuals is
reported to rarely exceed 25 years. 3 Brown and Goldstein5,6
have clearly demonstrated that the primary defect co=only
resides in the LDL-receptor gene.
Afrikaners have been in South Africa for 12 - 15 generations.
If a founder effect as suggested1,2,4 is correct, the presence of a
linkage disequilibrium between any marker on the LDL-
receptor gene and FH could be expected in South Africa.
To test this hypothesis we looked at the frequency distribu-
tion of a bi-allelic restriction fragment length polymorphism
(RFLP) on the LDL-receptor gene in a sample of Afrikaans-
speaking individuals and in a sample of patients from the same
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population group with predominantly high cholesterol levels.
Some of these patients have FH diagnosed by the usual
criteria.
Materials and methods
Sixty-five Afrikaans-speaking individuals, taken from laboratory
staff, hospital staff and patients attending the general outpatient
clinics of Tygerberg Hospital, were used to establish population
frequencies for the respective alleles of the bi-allelic marker in the
general population. TO other data were obtained from mese
individuals.
Thirty-four (16 male, 18 female) Afrikaans-speaking individuals
were used to establish the allele frequencies in the Tygerberg
Hospital Lipid Clinic. The hospital serves mainly the Afrikaans-
speaking population of me soum-western Cape. Plasma cholesterol
and triglyceride values and high-density lipoprotein cholesterol
ratios were those determined by me Department of Chemical
Pathology at Tygerberg Hospital on a routine basis. Individuals
with only hypertriglyceridaemia were not included in me study.
Where first-degree relationships were known to exist, only one
member of a family was included in the study.
Human DNA was obtained from whole blood, as previously
described: 7 10 Ilg DNA from each individual was digested with
the Pvu II restriction endonuclease (under manufacturer's condi-
tions), electrophoretically separated by size on 0,6% agarose gel,
washed in 0,25M HCl for 7,5 minutes to obtain efficient transfer
of large DNA fragments,S denatured and transferred to nitro-
cellulose by Southern blotting.
The LDL-receptor gene probe pLDLR-2HHI was donated by
Dr D. W. Russell of Dallas and consists of a 1,9 kb fragment (base
pairs 1573-3486) of the 3 end of the LDL-receptor cDNA clone.9
Plasmid DNA was prepared and isolated by the alkaline lysis
method. lo The 1,9 kb base fragment was excised as described 10
and nick-translated to a specific activity of at least IOs cpm/Ilg
probe DNA (using the nick translation kit and protocol supplied
by Bethesda Research Laboratories).
After baking at 80°C until dry, the nitrocellulose filters were
prehybridized for 5 minutes in a solution of 1% bovine serum
albumin fraction V, I mM ethylene diamine tetra-acetic acid
(EDTA), 7% sodium dodecyl sulphate (SDS), 0,5M NaHPO., pH
7,2. A 'IM Na-PO.' (pH 7,2) stock is composed ofO,5M Na2HP04
and 4 ml 85% H3PO/I (method modified from Church and
Gilbert ll ). The filters were hybridized at 65°C for 8 - 24 hours in
10 ml of the same solution to give a minimum of 106 cpm/ml.7
Post-hybridization washes consisted of two 5-minute washes at
65°C in a solution of 0,5% serum albumin fraction V, 160 mM
NaHPO., pH 7,2, I mM EDTA, 5% SDS and six 5-minute
washes at 65°C in a solution of I mM EDTA, 160 mM NaHPO.,
1% SDS, the last wash being left for 20 minutes. The filters were
then exposed to X-ray film for 1 - 4 days at -80°C.
Chi-square tests were performed to document mat the popula-
tions investigated were or were not in Hardy-Weinberg equilibrium
and to compare the chromosomal frequencies.
Results
Pvu 11 generates two bands of size 16,5 and 3,6 kb in the absence
and 14,0, 3,6 and 2,6 kb in the presence of a variable restriction
site detected with the LDL-receptor probe described (Fig. 1).'2,13
®
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TABLE I. GENOTYPE DISTRIBUTION AND ALLELE
FREQUENCY OF Pvu 11 RFLP IN THE AFRIKANER POPULA·
TION IN GENERAL AND IN INDIVIDUALS WITH HIGH
CHOLESTEROL LEVELS
No. of individuals
+ ++
-
2.6
General population
(N=65)
Hypercholesterolaemic
population (N= 34)
x' = 6,4 (l df); P < 0,05.
29
20
27
14
Frequency
+
9 0,653 0,346
o 0,794 0,206
TABLE 11. CHARACTERISTICS OF 34 PATIENTS ATTENDING
THE LIPID CLINIC
*Tygerberg Hospital Chemical Pathology Department routine tests.
tFamily history denotes the presence of a myocardial infarct or sudden death
before age 55 years in a first-degree relative.
HDL = high-density lipoprotein.
third possibility. A gene or genes causing hypercholesterolaemia
coupled to the '-' allele has been introduced in the Afrikaner
population.
The prevalence of FH among Afrikaners is high and a
founder effect has been suggested. I ,2,4 The response to a
cholesterol-lowering diet is usually poor among these
individuals ls and therefore they may cluster in specialized
lipid clinics in contrast to patients who respond well to diet.
The defect is heterogeneous and has been classified into five
classes on the basis of receptor studies. 16 The Afrikaner FH
might be homogeneous and of the so-called receptor-defective
type described by Van der Westhuyzen er al. 17
The presence of the linkage disequilibrium between a marker
on the LDL-receptor gene and high cholesterol levels in
patients anending a lipid clinic serving a predominantly Afri-
kaans-speaking community is therefore not unexpected. At the
same time it also provides additional evidence of a founder
effect.
The availability of more RFLPs coupled to the LDL-
receptor gene would aid in making a predictive diagnosis
about the presence or absence of FH in individuals in 90% or
more of families by doing classic linkage studies. 18 A new
RFLP is described elsewhere in this issue. 19 Haplotypes
(markers with several alleles) for the defect would also be
established and enable researchers to address the question
whether one or more abnormal LDL-receptor genes are present
®
'~I 16kb 0 3.6 'i5 ,
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Fig. 1. Pvu 11 RFLP detected with LDL-receptor cDNA probe
pLDLR-2HH1: ·(A) Southern blot analysis of the hybridization
pattern detected for the (I) ++, (il) --, and (iil) +- genotypes; (B)
diagram showing the relative positions of fragments detected on
the LDL-receptor gene. 12•13 The circle shows the variable Pvu 11
restriction site. .
The frequencies of the absence (-) and of the presence (+) of
the polymorphic restriction site in the general Afrikaans-speaking
population were 0,654 and 0,346 respectively; they differ from
those reported in other populations. 12,1 The genotypes '--', '-+',
'++' are in a Hardy-Weinberg population equilibrium (Table 1).14
The chromosomal frequencies of the alleles in the 34 hyper-
cholesterolaemic individuals are 0,794 and 0,206 for the '-' and
'+' allele respectively and the '-' is in a linkage disequilibrium
compared with the general population. The hypercholesterolaemia
phenotype is associated with the '-' allele more often than expected
(P < 0,5). The genotype '--', '+-' and '++' distribution is 20, 14
and °respectively for the 34 individuals and is not in a population
equilibrium for this group.
Table II shows the results of lipid analysis, the family history
and presence of the tendon xanthomas in the 34 patients.
Discussion
There are three different causes of a linkage disequilibrium
between a marker and a phenotype in a population: (I) the
marker is the cause of the phenotype; (il) the phenotype or the
marker is a new mutation, not coupled, but has not reached a
population equilibrium yet; and (iil) the marker or the pheno-
type is a newly introduced mutation, closely coupled and
unlikely to be dissociated in successive generations. The Pvu
II markers looked at occur elsewhere as normal variations in
populations,12,13 and the first possibility is therefore excluded
as a cause of the linkage equilibrium that we detected between
the '-' allele and hypercholesterolaemia in the selected study
group. The fact that Afrikaners have been in South Africa for
12 - 15 generations makes the second possibility unlikely, since
the markers and the hypercholesterolaemia phenotype should
have reached a population equilibrium by now. This leaves a
Age range (yrs)
Malelfemale ratio
Percentage
Total serum cholesterol (mmolll)"
No. of patients with total cholesterol
>6mmol/l
HDLltotal cholesterol ratio (%)
(range)
No. of patients with HDLltotal
cholesterol ratio < 20%
Serum triglyceride (mmol/l)
(range)
No. of patients with positive family
history (%)t
No. of patients with tendon
xanthomas (%)
47:53
Findings
14 - 66
16: 18
4,73 - 14,3
33
7 - 25
32
0,11 - 10,7
16 (47)
18 (53)
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in the Afrikaner population. Founders could be identified and
genetic counselling done more effectively.2o Family studies are
in progress.
It should in addition be possible to investigate the question
why receptor-defective FH is clinically so variable and,
generally speaking, less severe than other described defects2!
by correlating the vertical transmission of defective genes in
families with clinical and blood lipid studies.
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Nuus en Kommentaar/News and Comment
Verswakte bestuursvermoe - vergeet nie
die ander medisyne nie
Die meeste dwelms wat die sentrale senustelsel beinvloed, het ook
die potensiaal om 'n mororbesruurder se vermoe te verswak. In
hierdie groep wek alkohol steeds die meeste kommer, aangesien dit
verreweg die grootste oorsaak van motorongelukke is. Maar namate
al hoe meer middels soos bensodiasepien in gebruik geneem word,
moet die kollig ook op ander dwelms gerig word.
'n Konsensuspaneel van die nasionale instiruut vir dwelm-
misbruik in die VSA (JAMA 1985; 254: 2618) het hierop ingegaan
en o.m. gevind dat die misbruik van psigoaktiewe middeIs aan die
toeneem is en dat beter chemiese ontledingstegnieke nodig is om
verswakte besruurvermoens by motorryers te bewys. Daar bestaan
nog nie 'n tegniek om dwelms soos marijuana (dagga) of anti-
histamiene en bensodiasepiene doeltreffend in die liggaam te peil
nie en daar is min twyfel dat navorsing in hierdie rigring versnel
moet word.
Die eerste oorweging vir sulke navorsing moet egter gaan oor
die invloed van marijuana en bensodiasepiene, want die is die
algemeenste dwelms in gebruik. 'n Eykomstige srudie is ook nodig
om die uitwerking van dwelms in kombinasie met alkohol te
bepaal.
Die paneel se dat alhoewel die inligring oor die uitwerking van
alkohol op mororbesruurders al langer as 'n eeu beskikbaar is,
hierdie kennis ver van volledig is en sekere aspekte beslis verder
ondersoek moet word. Realistiese definisies met betrekking tot die
uitwerking van ander dwelms op die bestuursvermoe van 'n
motorryer is gegrond op ons ondervinding met alkohol, maar die
grense van bestuursvermoe is nog nie bepaal nie. Eers as dit
gedoen is, kan die ware werking van ander dwelms benewens
alkohol gepeil word. Eaie faktore soos liggaamsgewig, genetiese en
omgewingsinvloede sal in die srudie in gedagre gehou moet word
en metodes' om werklike toesrande waarin die motorryer horn
bevind te simuleer, sal waarskynlik die beste resultate in die toetse
lewer.
Hepatocellular carcinoma by perinatal
transmission
Hepatocellular carcinoma, one of the most intractable rumours to
treat, may well also be the commonest in the world. Its relation to
hepatitis E virus (HEV) infection and the subsequent HbsAg
carrier-state is now quite clear. The viral infection may be acquired
from tanooing, ritual circumcision, scarification by local healers,
or less frequently by blood transfusion or sexual intercoure.
However, there is another possibility, namely infection of an
infant immediately after birth from a mother who is a carrier of
the HEV surface antigen. Trounce er al. (QJ Med 1985; 57: 791)
report the very unusual case 'of a 9-year-old boy born of Chinese
parents in England and adopted by an English couple at an early
age who presented with primary hepatocellular carcinoma in a
non-cirrhotic liver. There was no past history of hepatitis or of
blood transfusion and he had not left England since his adoption.
His serum contained hepatitis E surface antigen and 'E' antibody
and the authors conclude that it is highly probable that this boy
acquired his HEV infection from his mother by perinatal trans-
mission.
The risk of transmission of HEV from mother to baby is
estimated to be 95% if mother is an HEeAg carrier, 70 - 90% if
clinicaLhepatitis E occurs in the last trimester of pregnancy, and
20% if mother is an HEsAg carrier but negative for both HEeAg
and anti-HEe.
Doctors in the UK are likely to discover more of these cases as
time goes by, with the large Third World community in the
country. The authors of the report believe that all mothers in high
HEsAg-carrier groups should be screened during pregnancy and if
positive their infants should be given immunobulin to induce
passive immunity straight away, preferably in the delivery room.
Active vaccination should also be instituted at birth. Now that
both passive and active immunoprophylaxis is possible, the eventual
eradication of this very dangerous HEV infection has become a
possibility, bur obviously not for many years to come.
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